GloBody Technology: Detecting Anti-Drug Antibody against VH/VL domains

The occurrence of anti-drug antibodies following administration of therapeutic monoclonal antibody to patients is a growing problem that is attracting attention from frontline clinicians. Ideally, an initial indicative point of care test would provide guidance to seek testing approved by the regulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Saxena, Gauri K., Theocharopoulos, Ioannis, Aziz, Nisha Thaslima, Jones, Meleri, Gnanapavan, Sharmilee, Giovannoni, Gavin, Schmierer, Klaus, Garnett, James A., Baker, David, Kang, Angray S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002611/
https://www.ncbi.nlm.nih.gov/pubmed/32024871
http://dx.doi.org/10.1038/s41598-020-58041-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002611/
https://www.ncbi.nlm.nih.gov/pubmed/32024871
http://dx.doi.org/10.1038/s41598-020-58041-3

Ejemplares similares